Literature DB >> 2826535

Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.

K Baba1, K Shiraki, T Kanesaki, K Yamanishi, P L Ogra, H Yabuuchi, M Takahashi.   

Abstract

Specificity of the skin test with varicella-zoster virus (VZV) antigen was examined in guinea pigs infected with herpes simplex virus (HSV) type 1 or VZV and in children with a history of HSV infection who developed varicella. Infected guinea pigs responded positively only to homologous virus. No cross-reaction between HSV and VZV was detected in the skin test, as well as in the neutralization test in infected guinea pigs, suggesting that the VZV skin test is specific for immunity to VZV infection. Twelve children were infected with HSV during an HSV epidemic and subsequently developed varicella in institutional settings. During the 2.5-month period between the HSV and VZV infections, the immune status of the children to VZV was negative both in the skin test and in the antibody test, although antibody to HSV was detected by an immune adherence hemagglutination test. After VZV infection, all responded positively both in the skin test and in the antibody test (immune adherence hemagglutination test) to VZV. These results suggest that the VZV skin test is specific for immunity to VZV infection, not cross-reactive to HSV infection in humans. This specificity will be of value in screening susceptibility or immunity to VZV, irrespective of prior HSV infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826535      PMCID: PMC269438          DOI: 10.1128/jcm.25.11.2193-2196.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Development of a live attenuated varicella vaccine.

Authors:  M Takahashi; Y Okuno; T Otsuka; J Osame; A Takamizawa
Journal:  Biken J       Date:  1975-03

2.  Diagnostic skin test reactions with varicella virus antigen and clinical application of the test.

Authors:  H Kamiya; T Ihara; A Hattori; T Iwasa; M Sakurai; T Izawa; A Yamada; M Takahashi
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

3.  Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster.

Authors:  Y Asano; M Takahashi
Journal:  Biken J       Date:  1978-03

4.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.

Authors:  N J Schmidt; E H Lennette; R L Magoffin
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

5.  Simultaneous rise in complement-fixing antibodies against herpesvirus hominis and varicella-zostervirus in patients with chickenpox and shingles.

Authors:  G J Schaap; J Huisman
Journal:  Arch Gesamte Virusforsch       Date:  1968

6.  Skin test with Varicella-zoster virus antigen on herpes zoster patients.

Authors:  S Hata
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

7.  Studies with live varicella vaccine and inactivated skin test antigen: protective effect of the vaccine and clinical application of the skin test.

Authors:  K Baba; H Yabuuchi; H Okuni; M Takahashi
Journal:  Pediatrics       Date:  1978-04       Impact factor: 7.124

8.  The serological relationship of varicella-zoster virus to other primate herpesviruses.

Authors:  D A Harbour; A E Caunt
Journal:  J Gen Virol       Date:  1979-11       Impact factor: 3.891

9.  Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus.

Authors:  A Yamada; S Ogino; Y Asano; T Otsuka; M Takahashi; K Baba; H Yabuuchi
Journal:  Biken J       Date:  1979-06

10.  Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens.

Authors:  J A Zaia; P L Leary; M J Levin
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

View more
  5 in total

1.  An intradermal skin test for determination of immunity to varicella.

Authors:  E Somekh; Y Bujanover; G Tal; I Dalal; A Tanay; D Lehman
Journal:  Arch Dis Child       Date:  2001-12       Impact factor: 3.791

Review 2.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

3.  Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.

Authors:  M Takayama
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

Review 4.  Impact of varicella vaccine on varicella-zoster virus dynamics.

Authors:  D Scott Schmid; Aisha O Jumaan
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

5.  Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster.

Authors:  Y Okuno; Y Takao; Y Miyazaki; F Ohnishi; M Okeda; S Yano; H Kumihashi; Y Gomi; K Maeda; T Ishikawa; Y Mori; H Asada; H Iso; K Yamanishi
Journal:  Epidemiol Infect       Date:  2012-12-10       Impact factor: 4.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.